Frank Zavrl
Directeur/Membre du Conseil chez CERVOMED INC.
Fortune : 7 M $ au 31/05/2024
Profil
Frank E.
Zavrl is currently a Non-Executive Director at EIP Pharma, Inc. and an Independent Director at CervoMed, Inc. He previously served as an Independent Director at Puma Biotechnology, Inc. from 2015 to 2020 and as a Director at EIP Pharma LLC in 2017 and 2018.
He also worked as an Equity Analyst at Adage Capital Management LP and as an Analyst at Zurich Scudder Investments, Inc. from 1998 to 1999.
Additionally, he was a Portfolio Manager at Merlin Biomed Group LLC from 1999 to 2002.
Mr. Zavrl obtained his undergraduate degree from the University of California, Berkeley and an MBA from the Tuck School of Business at Dartmouth.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERVOMED INC.
4,28% | 29/04/2024 | 353 009 ( 4,28% ) | 7 M $ | 31/05/2024 |
Postes actifs de Frank Zavrl
| Sociétés | Poste | Début |
|---|---|---|
| CERVOMED INC. | Directeur/Membre du Conseil | 16/08/2023 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Frank Zavrl
| Sociétés | Poste | Fin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 06/07/2020 |
| EIP Pharma LLC | Directeur/Membre du Conseil | 01/03/2018 |
Merlin Biomed Group LLC
 Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City | Corporate Officer/Principal | 01/01/2002 |
| Zurich Scudder Investments, Inc. | Corporate Officer/Principal | 01/01/1999 |
Adage Capital Management LP
 Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts. | Analyst-Equity | - |
Formation de Frank Zavrl
| University of California, Berkeley | Undergraduate Degree |
| Tuck School of Business at Dartmouth | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| CERVOMED INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Adage Capital Management LP
Adage Capital Management LP Investment ManagersFinance Adage Capital Management LP (Adage) is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Phil Gross and Robert Atchinson in 2001 and is owned by Adage Capital Partners GP LLC. Adage provides investment advisory services to its sole client, Adage Capital Partners LP (ACP), a private investment fund. The firm does not manage any separate accounts. | Finance |
| Zurich Scudder Investments, Inc. | Finance |
Merlin Biomed Group LLC
Merlin Biomed Group LLC Investment ManagersFinance Merlin Biomed Group LLC is a venture capital/private equity firm located in New York City | Finance |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology EIP Pharma, Inc. engages in the research and development of therapeutic drugs for the central nervous system disorders. It focuses on neflamapimod, which is a clinical-stage oral investigational drug for the treatment of brain diseases such as Alzheimer?s disease and for non-brain disorders including rheumatoid arthritis. The company was founded by John Alam and Sylvie Louise Gregorie and is headquartered in Cambridge, MA. | Health Technology |
| EIP Pharma LLC |
